Xilio Therapeutics, Inc. (XLO) KPIs & Operating Metrics

Name: XLO (Xilio Therapeutics, Inc.) KPIs and Operating Metrics
Creator: Signals.AI

Xilio Therapeutics, Inc. (XLO) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.

KPIs — source: SEC EDGAR, earnings calls, investor decks
Metric	Latest Value	Period
Development Milestone Payment Under License Agreement	17.5M	FY2025-Q4
Colitis Incidence (Patients Reporting Colitis)	7.00 percent	FY2025-Q3

Back to XLO overview · XLO earnings · XLO holders

Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.